Panagora Asset Management’s Travere Therapeutics TVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$6.39M Buy
432,021
+96,062
+29% +$1.42M 0.03% 315
2025
Q1
$6.02M Buy
335,959
+797
+0.2% +$14.3K 0.03% 316
2024
Q4
$5.84M Buy
335,162
+14,829
+5% +$258K 0.03% 319
2024
Q3
$4.48M Buy
320,333
+229,452
+252% +$3.21M 0.02% 364
2024
Q2
$747K Buy
+90,881
New +$747K ﹤0.01% 808
2024
Q1
Sell
-84,909
Closed -$763K 1260
2023
Q4
$763K Sell
84,909
-167,389
-66% -$1.5M ﹤0.01% 895
2023
Q3
$2.26M Sell
252,298
-40,084
-14% -$358K 0.01% 484
2023
Q2
$4.49M Buy
292,382
+90,385
+45% +$1.39M 0.03% 357
2023
Q1
$4.54M Buy
201,997
+100,465
+99% +$2.26M 0.03% 385
2022
Q4
$2.14M Buy
+101,532
New +$2.14M 0.01% 610
2021
Q3
Sell
-19
Closed 2352
2021
Q2
$0 Sell
19
-541
-97% ﹤0.01% 2950
2021
Q1
$14K Sell
560
-44,609
-99% -$1.12M ﹤0.01% 2351
2020
Q4
$1.23M Sell
45,169
-120,374
-73% -$3.28M 0.01% 888
2020
Q3
$3.06M Sell
165,543
-93,173
-36% -$1.72M 0.02% 511
2020
Q2
$5.28M Buy
258,716
+12,164
+5% +$248K 0.03% 383
2020
Q1
$3.6M Sell
246,552
-315,718
-56% -$4.61M 0.03% 434
2019
Q4
$7.98M Buy
562,270
+105,198
+23% +$1.49M 0.04% 377
2019
Q3
$5.3M Buy
457,072
+2,880
+0.6% +$33.4K 0.02% 447
2019
Q2
$9.13M Buy
454,192
+47,870
+12% +$962K 0.04% 355
2019
Q1
$9.2M Buy
406,322
+218,006
+116% +$4.93M 0.04% 376
2018
Q4
$4.26M Buy
188,316
+133,406
+243% +$3.02M 0.02% 506
2018
Q3
$1.58M Buy
+54,910
New +$1.58M 0.01% 934
2017
Q1
Sell
-32,235
Closed -$610K 2453
2016
Q4
$610K Buy
32,235
+27,886
+641% +$528K ﹤0.01% 1376
2016
Q3
$97K Buy
4,349
+1,974
+83% +$44K ﹤0.01% 1974
2016
Q2
$42K Hold
2,375
﹤0.01% 2091
2016
Q1
$32K Sell
2,375
-1,354
-36% -$18.2K ﹤0.01% 2082
2015
Q4
$71K Buy
3,729
+1,500
+67% +$28.6K ﹤0.01% 1887
2015
Q3
$42K Sell
2,229
-356
-14% -$6.71K ﹤0.01% 2037
2015
Q2
$83K Buy
+2,585
New +$83K ﹤0.01% 2006